cataliesw
| Joined: | Sat, Aug 12th 2023, 02:34 | Roles: | N/A | Moderates: | N/A |
Latest Topics
| Topic | Created | Posts | Views | Last Activity |
|---|---|---|---|---|
| Engineered Phage Lysins | Feb 22nd, 01:16 | 1 | 544 | on 22/2/25 |
| Cell Culture and Organ-On-A-Chip Model Development Services | Feb 22nd, 01:02 | 1 | 509 | on 22/2/25 |
| Zebrafish Antibody | Feb 22nd, 00:41 | 1 | 534 | on 22/2/25 |
| Development of FGFR-based Bispecific ADCs | Jan 24th, 01:49 | 2 | 1,159 | on 6/2/25 |
| antibody-drug conjugates | Jan 20th, 01:13 | 1 | 850 | on 20/1/25 |
| plasmids | Dec 9th 2024, 20:34 | 1 | 1,152 | on 9/12/24 |
Latest Posts
| Topic | Author | Posted On |
|---|---|---|
| Engineered Phage Lysins | cataliesw | on 22/2/25 |
| The modular structure of lysin is composed of at least two domains, including an N-terminal catalytic domain (CD) for enzymatic hydrolysis and a C-terminal cell wall binding domain (CBD) for substrate recognition. Learn more:Engineered Phage Lysins | ||
| Cell Culture and Organ-On-A-Chip Model Development Services | cataliesw | on 22/2/25 |
| MFMM1-Flow is an easy-to-use device for long-term 2D/3D cell culture and mechanical shear stress studies by means of microfluidics. Learn more: Cell Culture and Organ-On-A-Chip Model Development Services | ||
| Zebrafish Antibody | cataliesw | on 22/2/25 |
| Danio rerio (zebrafish) is a small fish that shines in biomedical research. Zebrafish lay hundreds of eggs that develop externally, allowing scientists to manipulate genes and monitor early phenotypes in complex organisms. Learn more: Zebrafish Antibody | ||
| Development of FGFR-based Bispecific ADCs | cataliesw | on 24/1/25 |
| An appealing and innovative treatment is the bispecific antibody-drug combination (ADC), which delivers targeted cytotoxic drugs with increased efficacy and less non-specific cytotoxic effects while directly targeting tumor-associated cell-surface antigens. Learn more: Development of FGFR-based Bispecific ADCs | ||
| antibody-drug conjugates | cataliesw | on 20/1/25 |
| Antibody-drug conjugates (ADCs) inherit such superiorities and more remarkably, expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature. | ||
